PhotoMedex (PHMD) Appoints New CEO
More News related to PHMD
- PhotoMedex Appoints Christina L. Allgeier Chief Financial Officer
- PhotoMedex Offers Free Seminar for Psoriasis Patients: "A Win for Your Skin in the Daily Fight Against Psoriasis"
- PhotoMedex Ranked 22nd in Deloitte's Technology Fast 50 Program for Greater Philadelphia
- PhotoMedex Raises $2.7 Million in Private Placement of Common Stock
- PhotoMedex Receives Notice from NASDAQ
PhotoMedex, Inc. (NASDAQ: PHMD) announced that Jeffrey O'Donnell, President and CEO, has resigned from the Company and the board of directors to pursue other business interests.
Mr. O'Donnell has led PhotoMedex since 1999, and under his leadership the Company has grown into a portfolio of dermatology focused businesses based on both sound science and compelling patient and consumer benefits. The Board of Directors of PhotoMedex thanked Mr. O'Donnell for his decade of committed service to the Company.
Related Categories
Management ChangesStocks Mentioned
-0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
